Showing results (2511-2520 of 9,905) with videos related to

Sort By:
Pageof 991
Bone Marrow Transplantation|April 12, 2011
Single center retrospective analysis of BU-based conditioning regimens in allogeneic transplantationA M Wong, J C Allen, Y T Goh, et al.
Bone Marrow Transplantation|March 15, 2011
Prognostic impact of iron parameters in patients undergoing allo-SCTG N Bazuaye, G N Bazuave, A Buser, et al.
Bone Marrow Transplantation|March 15, 2011
The role of HLA--G 14-bp polymorphism in allo-HSCT after short-term course MTX for GvHD prophylaxisP Chiusolo, S Bellesi, N Piccirillo, et al.
Bone Marrow Transplantation|April 5, 2011
What are a patient's current chances of finding a matched unrelated donor? Twenty years' central search experience in a small countryA Rosenmayr, M Pointner-Prager, A Mitterschiffthaler, et al.
Bone Marrow Transplantation|March 29, 2011
Idarubicin-intensified BUCY2 regimens may lower relapse rate and improve survival in patients undergoing allo-SCT for high-risk hematological malignancies: a retrospective analysisM Hong, Q Wu, C Hu, et al.
Bone Marrow Transplantation|March 29, 2011
Effect of genetic polymorphisms in genes encoding GST isoenzymes on BU pharmacokinetics in adult patients undergoing hematopoietic SCTM H ten Brink, J A Wessels, J den Hartigh, et al.
Bone Marrow Transplantation|March 29, 2011
Similar outcomes using myeloablative vs reduced-intensity allogeneic transplant preparative regimens for AML or MDSS M Luger, O Ringdén, M-J Zhang, et al.
Bone Marrow Transplantation|March 29, 2011
Diagnosis and treatment of pulmonary chronic GVHD: report from the consensus conference on clinical practice in chronic GVHDG C Hildebrandt, T Fazekas, A Lawitschka, et al.
Bone Marrow Transplantation|March 29, 2011
Identification by random forest method of HLA class I amino acid substitutions associated with lower survival at day 100 in unrelated donor hematopoietic cell transplantationS R Marino, S Lin, M Maiers, et al.
Bone Marrow Transplantation|June 1, 2019
Hematopoietic stem cell transplantation with unrelated cord blood or haploidentical donor grafts in adult patients with secondary acute myeloid leukemia, a comparative study from Eurocord and the ALWP EBMTAnnalisa Ruggeri, Myriam Labopin, Bipin Savani, et al.
Pageof 991